Immunovant, Inc.

IMVT ·Healthcare, Drug Manufacturers - General, United States
Financial Statements › SEC Filings

SEC Filings

Form Filed Description
8-K Jan 7, 2022 8-K
4 Jan 7, 2022 FORM 4
8-K Jan 5, 2022 8-K
8-K Dec 30, 2021 8-K
8-K Nov 23, 2021 8-K
8-K Nov 17, 2021 8-K
4 Nov 9, 2021 FORM 4
10-Q Nov 5, 2021 10-Q
8-K Nov 5, 2021 8-K
4 Oct 18, 2021 FORM 4
4 Oct 5, 2021 FORM 4
3 Oct 5, 2021 FORM 3
8-K Sep 27, 2021 8-K
4 Sep 16, 2021 FORM 4
8-K Sep 15, 2021 8-K
4 Sep 14, 2021 FORM 4
4 Sep 14, 2021 FORM 4
4 Aug 30, 2021 FORM 4
4 Aug 20, 2021 FORM 4
4 Aug 16, 2021 FORM 4
DEF 14A Aug 12, 2021 DEF 14A
4 Aug 11, 2021 FORM 4
10-Q Aug 9, 2021 10-Q
8-K Aug 9, 2021 8-K
4 Aug 4, 2021 FORM 4
← Newer Page 17 of 26 · 643 filings Older →